ORIG3N Closes $3.1 Million in Funding Lead by Hatteras Venture Partners

ORIG3N, Inc., a pioneer in regenerative medicine and provider of pluripotent stem cell storage, has raised $3.1 million in funding from an investor syndicate that includes Hatteras Venture Partners, Harris & Harris Group, KTB and Mountain Group Capital. The funding will be used to expand Life CapsuleTM which provides everyone the opportunity to contribute to the advancement of medical research of rare genetic inherited diseases and neurodegenerative diseases such as Parkinson's, Alzheimer's, MS and ALS.

http://ift.tt/1zm8J26